在COPD治疗中使用Fluticasone与Budesonide的双重疗法
William B Feldman1,2,3,4, Vidya L Ambati1, Samy Suissa5
1Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
JAMA network open
|March 9, 2026
概括
与其他吸入的长效皮质类固醇β-agonist吸入剂相比,每天一次的弗鲁蒂卡松furoate-vilanterol吸入剂显示,COPD恶化风险降低. 在所有研究的治疗方法中,肺炎住院的风险与所有研究的治疗方法相似.
科学领域:
- 肺部医学和药理学 肺部医学和药理学
- 临床结果研究研究
- 医疗保健服务研究 医疗服务研究
背景情况:
- 吸入性皮质类固醇长效β-agonist (ICS-LABA) 吸入器是COPD管理的标准.
- 治疗等价性经常被假定,但干粉和计量剂量吸入器之间存在环境影响 (温室气体排放) 和潜在的临床结果差异.
- 这项研究调查了不同ICS-LABA配方之间的临床结果变化.
研究的目的:
- 为了比较COPD恶化和肺炎住院病例在COPD成年人的三种ICS-LABA吸入器类型中.
- 分析与每天一次使用流他松酸维兰特醇 (干粉),每天两次使用流他松酸盐-沙米特醇 (干粉) 和每天两次使用布德索尼德-形式特醇 (计量剂量) 吸入器相关的结果.
主要方法:
- 一项使用美国商业索赔数据的纵向队列研究.
- 倾向性得分匹配 (1:1) 创建了40岁以上的COPD新ICS-LABA用户的三个比较队列.
- 主要结局:中度/重度COPD恶化和肺炎住院治疗,使用Cox比例危险回归分析.
主要成果:
- 弗卢蒂卡松酸-维兰特罗尔与比德尼德-福莫特罗尔 (HR,0.91;95% CI,0.88-0.94) 和比弗卢蒂卡松酸盐-萨尔米特罗尔 (HR,0.94;95% CI,0.89-0.98) 相比,恶化的风险降低了9% (HR,0.91;95% CI,0.88-0.94) 和风险降低了6%.
- 在流动松 propionate-salmeterol和budesonide-formoterol (HR,0.98;95% CI,0.95-1.01) 之间没有发现严重恶化风险的显著差异.
- 在任何比较的ICS-LABA吸入器组中,肺炎住院风险没有显著差异.
结论:
- 与每天两次服用布德化物-甲酸盐-沙米特醇干粉吸入器和每天两次服用布德化物-沙米特醇计量剂量吸入器相比,每天一次使用布德化物-甲酸盐-沙米特醇干粉吸入器显示,对COPD恶化的临床结果略有改善.
- 这项研究强调了ICS-LABA在COPD管理中的有效性.
- 需要进一步的研究,以充分阐明这些类内变异及其临床影响.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
1.0K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.0K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.8K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.8K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
591
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
591
Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
Inhaled Medications
936
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
936
Antiasthma Drugs: β2-Adrenoceptor Agonists
1.9K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.9K


